BERLIN (Reuters) – Switzerland signed a contract to buy Pfizer’s anti-viral drug Paxlovid to treat Covid-19, it said on Friday.
The European country said it had signed a contract to buy 12,000 packages and first treatments for certain at-risk patients would start this month.
(Reporting by Kirsti Knolle, Editing by Miranda Murray)
